Black Diamond Therapeutics, Inc. · NASDAQ:BDTX
Black Diamond Therapeutics, Inc. shareholders
As of Jun 30, 2026, 91 institutions reported holding Black Diamond Therapeutics, Inc., 61.0% of its shares. Largest: NEA Management Company, LLC, T. Rowe Price and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Black Diamond Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| NEA Management Company, LLC | 4.45M | 7.7% | no change | Aug 14, 2026 |
| T. Rowe Price | 4.07M | 7.1% | −6.5M | Aug 14, 2026 |
| BlackRock | 3.92M | 6.8% | +2.81M | Aug 7, 2026 |
| Vanguard | 2.86M | 5.0% | +639K | Aug 13, 2026 |
| Acadian Asset Management LLC | 2.35M | 4.1% | no change | Aug 13, 2026 |
| Renaissance Technologies | 1.96M | 3.4% | +319K | Aug 13, 2026 |
| Defilade Capital Management, L.P. | 1.67M | 2.9% | new | Aug 14, 2026 |
| Dimensional | 1.37M | 2.4% | +63,720 | Aug 11, 2026 |
| Geode Capital | 1.22M | 2.1% | +682K | Aug 12, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.09M | 1.9% | +34,488 | Aug 13, 2026 |